PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 5,170.00
+150.00 (2.99%)
At close: Aug 11, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 69.87 billion as of August 12, 2026. Its market cap has decreased by -16.76% in one year.
Market Cap
69.87B
Enterprise Value
58.17B
Revenue
13.71B
Ranking
n/a
PE Ratio
35.53
Stock Price
5,170.00
ChartMarket Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 69.87B, a decrease of -59.21%. That is a compound annual growth rate of -8.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 69.87B | -7.54% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CTCBIO | 78.42B |
| ABION | 75.78B |
| EyeGene | 72.41B |
| BIO-FD&C | 72.17B |
| QuadMedicine | 70.61B |
| IMGT Co.,Ltd. | 68.17B |
| AriBioLab | 65.13B |
| KoBioLabs | 64.37B |